Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Open-label Study Comparing 2 Different Strategies For Management Of Subjects With Plaque Psoriasis Who Have Responded To Etanercept Treatment

NCT00992394 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00992394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00992394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Open-label Study Comparing 2 Different Strategies For Management Of Subjects With Plaque Psoriasis Who Have Responded To Etanercept Treatment
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
April 30, 2013
Enrollment
174 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis